Myriad Genetics, Inc. (MYGN) has 12 identified peers for comparison in the Healthcare sector. Peers include ACRS, CDNA, CSTL, EXAS, GH, ILMN and others.
MYGN has a market capitalization of $459.13M, compared to an average peer market cap of $8.72B. MYGN is notably smaller than its average peer.
